BRULLO, CHIARA

BRULLO, CHIARA  

100006 - Dipartimento di Farmacia  

Mostra records
Risultati 1 - 20 di 184 (tempo di esecuzione: 0.049 secondi).
Titolo Data di pubblicazione Autore(i) File
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 1-gen-2009 Bruno, Olga; Brullo, Chiara; Bondavalli, Francesco; Schenone, Silvia; Spisani, S; Falzarano, Ms; Varani, K; Barocelli, E; Ballabeni, V; Giorgio, C; Tognolini, M.
2,3-Dihydro-1H-imidazo[1,2-b]pyrazole derivatives as potential neutrophils functions inhibitors 1-gen-2006 Bruno, Olga; Brullo, Chiara; Bondavalli, Francesco; Ranise, Angelo; Schenone, Silvia; Spisani, S; Falzarano, M. S.
2-Amino/Azido/Hydrazino-5-alkoxy-5H-[1]benzopyrano[4,3-d]pyrimidines: Synthesis and Pharmacological Evaluation 1-gen-2007 Bruno, Olga; Brullo, Chiara; Bondavalli, Francesco; Ranise, Angelo; Schenone, Silvia; M., Tognolini; V., Ballabeni; E., Barocelli
2-Aryl-3-phenylamino-4,5-dihydro-2h-benz[g]indazoles with analgesic activity 1-gen-2003 Schenone, Silvia; Bruno, Olga; Ranise, Angelo; Brullo, Chiara; Bondavalli, Francesco; W., Filippelli; F., Mazzeo; A., Capuano; G., Falcone
2-Phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives: New potent inhibitors of fMLP-induced neutrophil chemotaxis 1-gen-2007 Bruno, Olga; Brullo, Chiara; Bondavalli, Francesco; Ranise, Angelo; Schenone, Silvia; Falzarano, M. S.; Varani, K; Spisani, S.
3-Cyclopentyloxy-4-Methoxyphenyl-isoxazoline derivatives as new PDE4 inhibitors. 1-gen-2014 Rotolo, Chiara; Massa, Matteo; Meta, Elda; Brullo, Chiara; Bruno, Olga
3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors. 1-gen-2009 F., Falchi; F., Manetti; F., Carraro; A., Naldini; G., Maga; E., Crespan; Schenone, Silvia; Bruno, Olga; Brullo, Chiara; M. Botta, .
4-Amino-pyrazolo[3,4-d]pyrimidines with antiproliferative activity on osteosarcoma cell line SaOS-2 1-gen-2005 Schenone, Silvia; Bondavalli, Francesco; Brullo, Chiara; Bruno, Olga; Ranise, A.; Mosti, L.; Menozzi, G.; Fossa, Paola; Santucci, A.; Serchi, T.; Spreafico, A.; Botta, M.
5-alkoxy-2-hydrazino and 5-methoxy-2-amino-5H-[1]benzopyrano[4,3-d]pyrimidines: synthesis and pharmacological activity 1-gen-2005 Bruno, Olga; Brullo, Chiara; Schenone, Silvia; Ranise, Angelo; Bondavalli, Francesco; Tognolini, M; Ballabeni, V; Barocelli, E.
6-Substituted pyrazolo[3,4-d]pyrimidines: new promising compounds in the fight against Neuroblastoma 1-gen-2014 Musumeci, F.; Desogus, A.; Schenone, S.; Brullo, C.; Fallacara, A. L.; Tintori, C.; Dreassi, E.; Zamperini, C.; Maga, G.; Angelucci, A.; Botta,
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors. 1-gen-2013 Mori, M; Tintori, C; Christopher, Rs; Radi, M; Schenone, Silvia; Musumeci, Francesca; Brullo, Chiara; Sanità, P; Delle Monache, S; Angelucci, A; Kissova, M; Crespan, E; Maga, G; Botta, M.
A family of nitrogen-containing heterocycles as sirtuin inhibitors: synthesis and invitro biological evaluation 1-gen-2024 Falesiedi, M.; Scarano, N.; Grossi, G.; Carbone, A.; Brullo, C.; Musumeci, Francesca; Bruzzone, S.; Cichero, E.; Schenone, S.
A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo–Pyrazole Treatment in SKMEL-28 Melanoma Cells 1-gen-2024 Iervasi, Erika; Coronel Vargas, Gabriela; Bachetti, Tiziana; Tkachenko, Kateryna; Spallarossa, Andrea; Brullo, Chiara; Rosano, Camillo; Carta, Sonia; Barboro, Paola; Profumo, Aldo; Ponassi, Marco
A1 receptors ligands: past, present and future trends. 1-gen-2010 Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Bruno, Olga; Botta, M.
Ablation of specific long PDE4D isoforms increases neurite elongation and conveys protection against amyloid-β pathology 1-gen-2023 Paes, D.; Schepers, M.; Willems, E.; Rombaut, B.; Tiane, A.; Solomina, Y.; Tibbo, A.; Blair, C.; Kyurkchieva, E.; Baillie, G. S.; Ricciarelli, R.; Brullo, C.; Fedele, E.; Bruno, O.; van den Hove, D.; Vanmierlo, T.; Prickaerts, J.
Amelioration of functional and histopathological consequences after spinal cord injury through phosphodiesterase 4D (PDE4D) inhibition 1-gen-2024 Schepers, M.; Hendrix, S.; Mussen, F.; van Breedam, E.; Ponsaerts, P.; Lemmens, S.; Hellings, N.; Ricciarelli, R.; Fedele, E.; Bruno, O.; Brullo, C.; Prickaerts, J.; Van Broeckhoven, J.; Vanmierlo, T.
Amino-Pyrazoles in Medicinal Chemistry: A Review 1-gen-2023 Lusardi, Matteo; Spallarossa, Andrea; Brullo, Chiara
An update on dual Src/Abl inhibitors 1-gen-2012 Musumeci, Francesca; Schenone, Silvia; Brullo, Chiara; Botta, M.
An Update on JAK Inhibitors 1-gen-2019 Musumeci, Francesca; Greco, Chiara; Giacchello, Ilaria; Fallacara, Anna Lucia; Ibrahim, Munjed M; Grossi, Giancarlo; Brullo, Chiara; Schenone, Silvia
Analogs, formulations and derivatives of imatinib: A patent review 1-gen-2015 Musumeci, Francesca; Schenone, Silvia; Grossi, Giancarlo; Brullo, Chiara; Sanna, Monica